Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 06-2023 | 03-2023 | |
Operating Expenses | 18,341 | 14,386 | 0 | 9,125 | 7,201 |
Operating Income | -18,341 | -14,386 | N/A | -9,125 | -7,201 |
Interest Expense | 347 | 346 | 0 | 327 | 324 |
Other Income | 2,658 | 1,315 | 0 | 789 | 241 |
Pre-tax Income | -16,030 | -13,417 | 0 | -8,663 | -7,284 |
Net Income Continuous | -16,030 | -13,417 | N/A | -8,663 | -7,284 |
Net Income | $-16,030 | $-13,417 | $N/A | $-8,663 | $-7,284 |
EPS Basic Total Ops | -0.60 | -0.76 | N/A | -2.33 | -1.97 |
EPS Basic Continuous Ops | -0.60 | -0.76 | N/A | -2.33 | -1.97 |
EPS Diluted Total Ops | -0.60 | -0.76 | N/A | -2.33 | -1.97 |
EPS Diluted Continuous Ops | -0.60 | -0.76 | N/A | -2.33 | -1.97 |
EPS Diluted Before Non-Recurring Items | N/A | -0.76 | N/A | N/A | N/A |
EBITDA(a) | $-18,228 | $-14,289 | $N/A | $-9,013 | $-7,115 |